Home » Newsletters » BioWorld Asia

BioWorld Asia

April 8, 1998

View Archived Issues

OGS In US$50M Pfizer Deal; Raises £31M In LSE Float

Natural Enzyme Activity May Improve Gene Therapy

Swedish, Danish Health Sectors Attract US$537M In Two Years

Lion Bioscience Reports Dynamic First-Year Operations

Biota's Flu Drug Submitted For Approval In Australia

Oxagen Raises £8M In Financing For Gene Identification Programs

Cambridge Antibody, Progenitor Team Up For Drug Discovery

Gemini, Affymetrix To Study Genetic Links To Osteoporosis

Biomira To Sell Diagnostics Subsidiary To Centocor

Agen Valued Higher Than Proposed Takeover Bid

Pharmos Gets 2 FDA Approvals; Eyes First Drug Revenues

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...